Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.0760
+0.0059 (8.42%)
At close: May 13, 2025, 4:00 PM
0.0750
-0.0010 (-1.32%)
After-hours: May 13, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K